This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin’s lymphoma: novel targets with impact on ERK signaling and cell migration
Cell Communication and Signaling Open Access 27 May 2021
-
Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy
Clinical Epigenetics Open Access 19 October 2020
-
Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy
Biomarker Research Open Access 14 August 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sanchez-Beato M, Sanchez-Aguilera A, Piris MA . Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220–1235.
Ward AC, Touw I, Yoshimura A . The Jak–Stat pathway in normal and perturbed hematopoiesis. Blood 2000; 95: 19–29.
Alexander WS . Suppressors of cytokine signaling (SOCS) in the immune system. Nat Rev Immunol 2002; 2: 410–416.
Wu C, Sun M, Liu L, Zhou GW . The function of the protein tyrosine phosphatase SHP1 in cancer. Gene 2003; 306: 1–12.
Chim CS, Liang R, Tam C, Kwong YL . p15 and p16 promoter methylation in acute promyelocytic leukemia. J Clin Oncol 2001; 19: 2033–2040.
Nagai H, Naka T, Terada Y, Komazaki T, Yabe A, Jin E et al. Hypermethylation associated with inactivation of the SOCS1 gene, a JAK/STAT inhibitor, in human hepatoblastomas. J Hum Genet 2003; 48: 65–69.
Oka T, Ouchida M, Koyama M, Ogama Y, Takada S, Nakatani Y et al. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res 2002; 62: 6390–6394.
Veillette A, Latour S, Davidson D . Negative regulation of immunoreceptor signaling. Annu Rev Immunol 2002; 20: 669–707.
Acknowledgements
We express our sincere thanks to Dr Junjiro Tsuchiyama for the NK-YS cell line and all medical and nursing staff in the Department of Medicine, Queen Mary Hospital for the provision of expert medical care.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Chim, C., Wong, K., Loong, F. et al. SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. Leukemia 18, 356–358 (2004). https://doi.org/10.1038/sj.leu.2403216
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403216
This article is cited by
-
SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker
Oncogene (2023)
-
miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin’s lymphoma: novel targets with impact on ERK signaling and cell migration
Cell Communication and Signaling (2021)
-
Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy
Clinical Epigenetics (2020)
-
Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma
Leukemia (2019)
-
STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
Leukemia (2014)